Brief: COMPASS Pathways Q3 EPS USD -0.56
31/10/2024 10:30
Oct 31 (Reuters) - COMPASS Pathways Q3 operating income USD -47.896 million vs. IBES estimate USD -42.8 million. * Q3 pretax profit USD -38.329 million * Q3 operating expenses USD 47.896 million * Q3 net income USD -38.502 million
Recent news on COMPASS Pathways
See all newsBrief: Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Trump's psychedelic drug order boosts investor interest with promise of faster reviews
UK's Compass Pathways Q1 operating income beats estimates as expenses fall
Health Rounds: Researchers gain new insight into how psychedelics affect the brain
U.S. STOCKS ON THE MOVE-Eli Lilly, Compass Pathways, Charter Communications